Clinical Research Malaysia

Clinical Research Malaysia Facilitating your clinical trial needs in Malaysia. https://clinicalresearch.my t: +603 7960 5153 | f: +603 7932 1940 | e: contact@clinicalresearch.my

Established by Malaysian Ministry of Health in 2012, Clinical Research Malaysia exists to advance global health solutions for a brighter, more hopeful future for the people by providing speedy and reliable end-to-end clinical research support for quality studies. Our innate understanding of the local clinical research landscape with the international standards of operations coupled with fundamental backing of the government ministries provide us an incomparable advantage to work with partners from the nascent stages of development to materialisation of the end product, in order to deliver better treatment and high skilled job opportunities.

-------------------------------------------------------------------------------------------------

Clinical Research Malaysia
Suite E-10-20, Amcorp Business Suites, Manara Melawangi,
Amcorp Trade Centre, No. 18, Jalan Persiaran Barat,
46050 Petaling Jaya, Selangor Darul Ehsan, Malaysia.

Congratulations Dr Rosaida Binti Hj Md Said and study team of Serdang Hospital in randomizing their first patient in Mal...
18/11/2025

Congratulations Dr Rosaida Binti Hj Md Said and study team of Serdang Hospital in randomizing their first patient in Malaysia for Ulcerative Colitis study. Excellent work from our Study Coordinators as well, Irdina, Rohaya, Lee Choon Yung and Afiqah for their contribution! Keep it up!

⁠ ⁠

Situated in Rumah Sakit Cipto Mangunkusoma (RSCM), the Eijkman Building stood in time having witnessed significant break...
17/11/2025

Situated in Rumah Sakit Cipto Mangunkusoma (RSCM), the Eijkman Building stood in time having witnessed significant breakthroughs in science. The building was titled after Dutch Nobel Laurate Christiaan Eijkman who during his directorship in that institution had discovered the causative factor of thiamine in Beriberi.

Now, the Eijkman Building houses both the Biomedical & Genome Science Initiative (BGSi) as well as the Clinical Research Unit (CRU) of RSCM, driving frontier in precision medicine and translating it to clinical practice. The BGSi program that is Indonesia's integrated genomic research initiative has now advanced to its 2nd phase of scale up, and is supported by group of talented young minds who are excitied to contribute to the development of science in this nation-led program.

During CRM's visit to the facility, we also re-connected with CRU RSCM, and had virtual engagements with CRUs from RS M Djamil as well as Dharmais Cancer Hospital. Great work led by the clinical research teams in ID, cancer as well as metabolic diseases, and truly look forward to elevated presence of these institutions in global clinical trials.

CRM had the honour of meeting the Minister of Health Indonesia, Yth Mr Budi Gunadi Sadikin, during when we shared insigh...
17/11/2025

CRM had the honour of meeting the Minister of Health Indonesia, Yth Mr Budi Gunadi Sadikin, during when we shared insights from Malaysia’s journey in building a robust clinical trial ecosystem it is today.

We also highlighted how Indonesia is poised for exceptional outcomes, with INA-CRC leading transformative efforts.

As Indonesia strengthens its position as a global clinical trial player, the combined force of Southeast Asia will create a formidable footprint -enhancing regional impact, accelerating innovation, and bringing meaningful benefits to patients across the region. Regional prosperity for all!

The Strengthening Indonesia Clinical Trial Ecosystem workshop was organised yesterday by both the WPRO office World Heal...
14/11/2025

The Strengthening Indonesia Clinical Trial Ecosystem workshop was organised yesterday by both the WPRO office World Health Organization and Indonesia Clinical Research Center (INA-CRC). CRM CEO Dr Akhmal Yusof was invited to share Malaysia's experience in enabling delivery of sponsored clinical trials with speed, quality and reliability. The establishment of CRM that was realised by our forefathers then, have truly paved the way succesful management and delivery of global trials in Malaysia.

Prior to the workshop, CRM also had a discussion the Director General of Pharmacy and Medical Devices (Ministry of Health Indonesia) Ibu Rizka Andalusia, accompanied by Ibu Indri Rooslamiati, Director of INA-CRC, sharing on CRM's journey and perspective in expanding clinical research for the region.

CRM was part of an 8-member delegation to Republic of Korea, a program organised by MIDA, purposed to explore R&D collab...
13/11/2025

CRM was part of an 8-member delegation to Republic of Korea, a program organised by MIDA, purposed to explore R&D collaborations and investment ventures with pharmaceutical industry partners in ROK. With meets with industry leaders like Hanmi Pharmaceuticals, Chong Kun Dang Pharmaceuticals & Korean United Pharma, as well as re-connecting with leading CRO LSK Global, CRM shared on Malaysia's footprint in global clinical trials, especially in delivery of trials with Speed, Quality and Reliability. Concluding the program was a seminar with pharma industry representatives, sharing on the holistic ecosystem in Malaysia, that is supportive and very much focused in driving the healthcare industry, including clinical research.

CRM met with Dr Kavinash from the National Cancer Society Malaysia (NCSM) and Dr Zaleha Mahdy from Project ECHO Malaysia...
13/11/2025

CRM met with Dr Kavinash from the National Cancer Society Malaysia (NCSM) and Dr Zaleha Mahdy from Project ECHO Malaysia to learn more about the ECHO model and its potential to enhance patient recruitment and awareness for clinical trials.

The Project ECHO framework, which follows the principle “Everyone teaches, everyone learns,” has been successfully adopted worldwide to build capacity and share knowledge across healthcare networks. The discussion explored how the ECHO approach and the survivor-navigator model could be adapted locally to empower patients and encourage participation in cancer and NCD clinical trials in Malaysia.

CRM looks forward to continued collaboration and innovation to make clinical research more accessible, inclusive, and patient-centred.

CRM has successfully completed the ISO 9001:2015 (Quality Management System) and ISO 37001:2016 (Anti-Bribery Management...
12/11/2025

CRM has successfully completed the ISO 9001:2015 (Quality Management System) and ISO 37001:2016 (Anti-Bribery Management System) surveillance audits with zero non-conformities!

From 10 to 11 November 2025, we had the pleasure of welcoming Dr Sethuraman Ramasamy, Puan Suri Yati Amran, and Puan Maznah Mat Isa from SIRIM QAS International Sdn Bhd to CRM Headquarters, as well as to our study sites at Hospital Sultanah Bahiyah and Hospital Seberang Jaya.

This achievement reaffirms our unwavering commitment to Speed, Reliability, and Quality in everything we do. It reflects the dedication of the entire CRM team in upholding the highest international standards, ensuring trust, transparency, and exceptional value for our stakeholders.

CRM was honoured to participate in the SLE Symposium 2025, organised by Persatuan SLE Malaysia a few weeks ago. CRM was ...
12/11/2025

CRM was honoured to participate in the SLE Symposium 2025, organised by Persatuan SLE Malaysia a few weeks ago. CRM was represented by Dr. Shereen Ch’ng Suyin, Consultant Rheumatologist from Hospital Selayang, who delivered a presentation titled “Clinical Trials in SLE: A Guide for Patients.”

The symposium was attended by over 100 participants, including patients, healthcare professionals, caregivers, and members of the public. It served as an excellent platform to enhance understanding of Systemic Lupus Erythematosus (SLE) and to share knowledge on patient care and current research developments.

CRM extends its sincere appreciation to Dr. Shereen for representing the organisation and sharing valuable insights on clinical trials in SLE. We also congratulate Persatuan SLE Malaysia for successfully organising an impactful and informative event that continues to support and empower the lupus community.

12/11/2025

Address

D-26-06, Menara Suezcap 1, KL Gateway, No. 2, Jalan Kerinchi, Gerbang Kerinchi Lestari
Kuala Lumpur
59200

Opening Hours

Monday 08:30 - 17:30
Tuesday 08:30 - 17:30
Wednesday 08:30 - 17:30
Thursday 08:30 - 17:30
Friday 08:30 - 17:30

Telephone

+60379315566

Website

Alerts

Be the first to know and let us send you an email when Clinical Research Malaysia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Clinical Research Malaysia:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

Clinical Research Malaysia (CRM) was established by the Malaysian Ministry of Health in 2012 with its sole existence anchored on advancing global health solutions for a brighter, more hopeful future for the people. To that end, we provide speedy and reliable end-to-end clinical research support for quality studies to our partners. In our pursuit of excellence, we continuously strive to improve on the delivery of our expertise to meet our partners’ needs by tapping into the breadth and depth of our organisation’s clinical research prowess. As these studies unfold, we work together with our partners to create an impetus in delivering better treatment to patients, while at the same time creating high-skilled job opportunities.

The strength of our operation lies in of our innate understanding of the local clinical research landscape and implementation of international standards.This, when considered in parallel to the fundamental backing of the government ministries, provides us with an incomparable advantage, as we work hand-in-hand with our partners from the nascent stages of development to materialisation of the end product.

In the journey towards a brighter and better future, we facilitate the entry of industry-sponsored research into Malaysia, working closely with the government and relevant authorities to ensure that all regulations and best practices are met.

Having cumulated a wealth of experience in the clinical research industry, we recognise that pivotal factors such as financial prudence, speed in delivery quality end product and reliability form the core of our integrity among our partners. As such, we ensure core values of transparency, honesty, accountability and trustworthiness resonate throughout CRM. These values make up our DNA and are evident in our practices regardless of whether we are fronting patients, partners or patrons, or in our individual workplaces – the ethical conduct form the core of our culture. These values are also cascaded to our principal investigators and study coordinators, who act as the catalysts of the clinical research process.